BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q2 2019 Results Conference Call August 6, 2019 8:30 AM ET Company Participants Vimal Mehta - CEO Richard Steinhart - CFO Frank Yocca - Chief Scientific Officer Vincent O'Neill - SVP & Chief Medical Officer Conference Call Participants Andrea Brettler - UBS Edward White - H.C. Wainwright Operator Good morning, and welcome to BioXcel Therapeutics Second Quarter 2019 Earnings Conference Call and Audio Webcast. Before we start, I would like to inform you that this confer ...